Cori Clinical announced USD 4 million in seed funding on Wednesday 7 October 2026, led by Breega. Jorn Jansen Schoonhoven and Patricio Fernández are building clinical-trial planning software through the London company. The product aims to reduce design problems and amendments that can delay research and increase costs. Its funding story concerns a defined stage in medical development: the preparation of trials before and during their execution. The investment connects a specialised founding team with capital supporting its software business. Cori Clinical's work applies technology to the planning decisions that influence how research programmes are organised and developed over time.
Cori Clinical raises USD 4m seed funding
Breega backs software for planning clinical trials

Keep reading
More Funding

BrightAI secures USD 97 million to scale physical AI infrastructure
Smith Point Capital led the investment in sensor based monitoring for essential services.

Dcubed raises EUR 27.2 million to expand space hardware production
Warsaw Equity Group led the oversubscribed Series A plus round for the German manufacturer.

Linq raises USD 90 million to expand AI powered mobile infrastructure
Andreessen Horowitz led the Series B and partner Ben Horowitz joined the board.


